ACTRN12609000432213招募中3 期
A randomised controlled trial of oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial)
Professor David Johnson0 个研究点目标入组 60 人开始时间: 2009年6月10日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1.On peritoneal dialysis for 1 month or longer.
- •2.On DPO for 1 month or longer.
- •3.18 years or over.
- •4.Able to give informed consent.
排除标准
- •1.Patients with a history of psychological illness or condition which interferes with their ability to understand or comply with the requirements of the study.
- •2.Pregnancy or breast-feeding.
- •3.Known hypersensitivity to, or intolerance of, oral iron, HIP or DPO.
- •4.Active peptic ulcer disease.
- •5.Vitamin B12 or folate deficiency.
- •6.Recent (within 1 month) acute infection.
- •7.Parathyroid hormone level > 100 pmol/L.
- •8.Serum aluminium > 2 micromol/L.
- •9.Presence of systemic haematological disease (including antibody-mediated pure red cell aplasia) or known haemoglobinopathy
- •10.Major surgery, infection, acute myocardial infarction or malignancy within the last 3 months.
- •11.Intravenous iron therapy, vitamin C therapy, melatonin treatment, androgen therapy or blood transfusion within the previous month.
- •12.Serum ferritin 500 microgram/mL or greater or transferrin saturation (TSAT) 50% or greater.
- •13.Religious or other objection to consuming product prepared from bovine blood.
研究者
相似试验
已完成
4 期
HEMATOCRIT Trial: A randomised controlled trial of oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets for the correction of anaemia in peritoneal dialysis patientsdarbepoetin-treated peritoneal dialysis patientsAnaemia in peritoneal dialysis patients treated with darbepoetinRenal and Urogenital - Kidney diseaseACTRN12610000678099Amgen60
尚未招募
不适用
Malaria and Iron deficiency studyHaematological DisordersPaediatricsMalariaPACTR2010050002141682College of Medicine600
尚未招募
不适用
Randomized controlled trial to compare oral iron to parenteral iron therapy for correction of iron deficiency in chronic kidney disease.CTRI/2020/04/024881Dr Manu Dogra
进行中（未招募）
不适用
A clinical open, randomised study of oral iron (Duroferon®) vs. intravenous iron (Ferinject®) for iron substitution in blood donors.Iron deficiency.MedDRA version: 9.1Level: LLTClassification code 10022972Term: Iron deficiency anaemiaMedDRA version: 9.1Level: LLTClassification code 10022975Term: Iron deficiency anemia secondary to blood loss (chronic)EUCTR2009-010623-64-SERenapharma AB210
已完成
2 期
A clinical trial to evaluate iron preparation effect for the pulmonary hypertension secondary in chronic respiratory disease patientsChronic respiratory failure patients with pulmonary arterial hypertensionJPRN-UMIN000007840Osaka City General Hospital Department of Respiratory Medicine41